Washington – The Natural Products Association (NPA) issued the following statement on the FDA’s FY 2025 Budget Request.
“Year after year, the FDA’s budget proposal includes mandatory product listing. Congress has routinely shut down this proposal, another example of the FDA being distracted from doing the basics,” said Daniel Fabricant, Ph.D. president and CEO of NPA. “While the FDA continues to receive more funding, the previous price tag for mandatory product listing was $34 million and does not include the millions spent for the NIH Dietary Supplement Label Database.”
In 2022, House and Senate leaders successfully prevented mandatory product listing from being included in the FDA User Fee Reauthorization. These influential members of Congress expressed significant concerns with mandatory product listing. “Congress has spoken on this issue, and giving FDA an administrative excuse to reject ingredients from being marketed as dietary supplements, regardless of the science or history, is a non-starter.”
